This article describes the formulation of a tablet for a specific purpose ... The principal properties of the ingredients have been used as a means of reducing the number of runs in factorially ...

“Orally disintegrating tablets are a standard in other disease areas such as migraine and would be of benefit to many people with HAE, particularly younger patients. We expect this formulation ...

The new 5mg tablet is expected to be available in the coming weeks and is suitable for use in patients aged two years and older who weigh more than 20kg, Roche said, adding that the original ...